Trial Details
Not RecruitingBasic Information
| Clinical ID | c3261 |
|---|---|
| Identifier | ISRCTN31320381 |
| Trial Title | Assessment of a multistrain probiotic (symprove) as a dietary supplement in patients with inflammatory bowel disease who are in 'clinical' remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel disease (ulcerative colitis and Crohn's disease) Digestive System Inflammatory bowel disease |
| Interventions | 160 patients with mild/moderate IBD will be randomly assigned (1:1 UC and 1:1 Crohn's disease) to receive 1 ml/kg/day (max 100 ml) of probiotic or placebo for 4 weeks. |
Participant Information
| Sponsor | Kings College Hospital NHS Foundation Trust (UK) |
|---|---|
| City | - |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |